Implants News and Research

RSS

Phasefocus invited to present a two day workshop on label-free cell imaging at CATIM

Phase Focus Ltd (Phasefocus), the company that is revolutionising microscopy and imaging with the Phasefocus Virtual Lens®, has been invited to present a two day workshop on label-free cell imaging at CATIM – the Centre for Alternative Testing and In-vitro Monitoring on Tuesday 24th and Wednesday 25th June. The meeting will take place at the Frenchay Campus of the University of the West of England, Bristol.

From Phase Focus Limited 6 May 2014

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Tufts University today announced that it has licensed a novel silk technology for the treatment of chronic skin wounds to Akeso Biomedical, Inc., an early stage medical device company.

6 May 2014

Restoring vision in patients with retinitis pigmentosa: an interview with Dr. Gregoire Cosendai, Vice President, Europe, Second Sight

Retinitis pigmentosa (RP) is a progressive eye disease that leads to untreatable blindness. The name of the disease derives from the fact that one of the areas affected by the disease is the retinal pigment epithelium (RPE) in the back of the eye.

30 Apr 2014

Braeburn announces new clinical trial for Probuphine based on clear guidance from FDA

Braeburn Pharmaceuticals announced today the initiation of a new clinical trial for Probuphine® based on clear guidance from the U.S. Food and Drug Administration (FDA). The study, which was submitted for FDA review in mid-March, is expected to begin enrollment by mid-year and to be completed by the middle of 2015.

30 Apr 2014

Sorin Group's Mitroflow Aortic Pericardial Heart Valve with PRT gets approval from FDA

Sorin Group, a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received U.S. Food and Drug Administration approval for the Mitroflow Aortic Pericardial Heart Valve with PRT.

28 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

The development of graphene-a highly advanced metamaterial with many unique and varied properties-may lead to exciting new applications in the diagnosis and treatment of neurological diseases, according to a report in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

26 Apr 2014

Research grants could improve patients' recovery from athletic and nonathletic injuries

Two orthopedic organizations have presented Beaumont Health System with prestigious, competitive research grants that could improve patients' recovery from both athletic and nonathletic injuries.

23 Apr 2014

VHVI implants miniaturized HeartWare HVAD Pump through minimally invasive approach

Sometimes smaller is better. This is especially true of left ventricular assist devices, the mechanically operated heart pumps that are implanted in heart failure patients to bridge them to transplantation.

23 Apr 2014

New FDA-approved device reduces seizures in patients with medication-resistant epilepsy

A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.

23 Apr 2014

FDA approves Cochlear's Aqua+ accessory for cochlear implant recipients

Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration has approved the Aqua+ accessory, the only waterproof behind-the-ear solution for cochlear implant recipients on the market today.

21 Apr 2014

Longer Looks: HIV epidemic in the Deep South; planning for Alzheimer's; Obamacare conspiracy theory

One of the strangest things about the H.I.V. epidemic in the Deep South-;from Louisiana to Alabama to Mississippi-;is how easily most Americans have elided it, choosing instead to imagine that the disease is now an out-there, elsewhere epidemic.

18 Apr 2014

ulrich medical USA announces release of tezo spine implants in the U.S. market

ulrich medical USA, Inc., today announced the U.S. market release of the tezo spine implants for multiple surgical approaches to lumbosacral interbody fusion.

16 Apr 2014

Tissue reconstruction using autologous engineered implants has been successfully achieved in humans

Reconstruction of damaged/absent tissue using engineered autologous (from the patients’ own cells) implants has been successfully achieved in humans for the first time.

11 Apr 2014

Abbott completes enrollment of 3 clinical trials to support approval of Absorb Bioresorbable Vascular Scaffold

Abbott (NYSE: ABT) today announced it has completed enrollment of three clinical trials to support approvals of the company's revolutionary Absorb™ Bioresorbable Vascular Scaffold (BVS) in the United States, Japan and China.

10 Apr 2014

Mazor launches new Renaissance Guidance System brain module at AANS annual meeting

Mazor Robotics will debut and officially launch the new Renaissance Guidance System brain module at the American Association of Neurological Surgeons (AANS) annual meeting. The Renaissance system is FDA-cleared for both spine and brain surgery.

2 Apr 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and transcatheter aortic valve replacement (TAVR).

2 Apr 2014

Study of non-surgically implanted replacement pulmonary valve shows strong results

The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in patients with certain congenital heart defects, according to research presented by a U-M pediatric interventional cardiologist at the American College of Cardiology's 63rd Annual Scientific Session Sunday.

1 Apr 2014

Researchers develop new responsive coating for implants used in surgery

A research group at Uppsala University, Sweden has developed a new responsive coating for implants used in surgery to improve their integration into bone and to prevent rejection. Neutron scattering experiments at the Institut Laue-Langevin (ILL) in Grenoble, France have shown how a protein that promotes bone growth binds to this surface and can be released in a controlled way.

31 Mar 2014

Breast lift procedures growing at twice the rate of breast implant surgeries

New statistics released today by the American Society of Plastic Surgeons show that breast lift procedures are growing at twice the rate of breast implant surgeries. Since 2000, breast lifts have grown by 70 percent, outpacing implants two-to-one. Breast implants are still by far the most performed cosmetic surgery in women, but lifts are steadily gaining. In 2013, more than 90,000 breast lift procedures were performed by ASPS member surgeons.

31 Mar 2014

Implants News and Research

Phasefocus invited to present a two day workshop on label-free cell imaging at CATIM

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Restoring vision in patients with retinitis pigmentosa: an interview with Dr. Gregoire Cosendai, Vice President, Europe, Second Sight

Braeburn announces new clinical trial for Probuphine based on clear guidance from FDA

Sorin Group's Mitroflow Aortic Pericardial Heart Valve with PRT gets approval from FDA

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

Research grants could improve patients' recovery from athletic and nonathletic injuries

VHVI implants miniaturized HeartWare HVAD Pump through minimally invasive approach

New FDA-approved device reduces seizures in patients with medication-resistant epilepsy

FDA approves Cochlear's Aqua+ accessory for cochlear implant recipients

Longer Looks: HIV epidemic in the Deep South; planning for Alzheimer's; Obamacare conspiracy theory

ulrich medical USA announces release of tezo spine implants in the U.S. market

Tissue reconstruction using autologous engineered implants has been successfully achieved in humans

Abbott completes enrollment of 3 clinical trials to support approval of Absorb Bioresorbable Vascular Scaffold

Mazor launches new Renaissance Guidance System brain module at AANS annual meeting

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Study of non-surgically implanted replacement pulmonary valve shows strong results

Researchers develop new responsive coating for implants used in surgery

Breast lift procedures growing at twice the rate of breast implant surgeries

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News